+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Serological evaluation of the macrofilaricidal effects of diethylcarbamazine treatment in bancroftian filariasis



Serological evaluation of the macrofilaricidal effects of diethylcarbamazine treatment in bancroftian filariasis



American Journal of Tropical Medicine and Hygiene 44(5): 528-535



An Mr 200,000 phosphorylcholine-containing antigen (PC-Ag) of predominantly adult worm origin was found in the sera of humans infected with Wuchereria bancrofti. This paper describes results of a longitudinal study of changes in levels of PC-Ag in response to diethylcarbamazine (DEC) therapy as measured by two-site immunoradiometric assay (IRMA) and Western blotting. One hundred thirty-two residents of a bancroftian filariasis-endemic area of Papua New Guinea (PNG) were treated with a 72 mg/kg dose of DEC. A macrofilaricidal effect was seen with this dose of DEC as 34% of the treated subjects had localized side effects and long-term decreases in microfilariae (mf) counts were observed 12 months after treatment. The PC-Ag levels were reduced to 72%, 52%, and 51% of pretreatment values at 21 days and at six and 12 months after treatment. These decreases, observed by IRMA, were specifically associated with loss of the Mr 200,000 PC-Ag detected by immunoadsorption and Western blotting. From drug treatment data, the maximum half-life of PC-Ag in circulation was calculated to be 50 days, assuming a first-order decay process. This maximum half-life indicates that persistent antigenemia observed in the majority of treated subjects could only result from the survival of adult worms. In the absence of methods to directly demonstrate W. bancrofti adult worms, detection of serum PC-Ag levels provides a sensitive indirect measure of the dynamics of adult worm populations. This serological measurement may be useful in optimizing the macrofilaricidal and therapeutic effects of DEC and in assessing the macrofilaricidal action of new antifilarial drugs and immunological interventions.

(PDF emailed within 1 workday: $29.90)

Accession: 002219420

Download citation: RISBibTeXText

PMID: 2063956


Related references

Macrofilaricidal activity and amelioration of lymphatic pathology in bancroftian filariasis after 3 weeks of doxycycline followed by single-dose diethylcarbamazine. American Journal of Tropical Medicine and Hygiene 81(4): 702-711, 2009

Predictors of systemic side effects of diethylcarbamazine treatment of bancroftian filariasis. Clinical Research 35(3): 494A, 1987

Diethylcarbamazine treatment of bancroftian and malayan filariasis with emphasis on side effects. Annals of Tropical Medicine and Parasitology 86(4): 399-405, 1992

Bancroftian filariasis: long-term effects of treatment with diethylcarbamazine in a Haitian population. American Journal of Tropical Medicine and Hygiene 45(6): 728-733, 1991

Studies on the epidemiology and control of filariasis. III. Mass treatment with diethylcarbamazine in endemic areas of bancroftian filariasis.. Endemic Diseases Bulletin of Nagasaki University. 3: 4, 289-298, 1961

Trend of bancroftian filariasis in two villages and long term effects of mass diethylcarbamazine treatment. Journal of Communicable Diseases 8(1): 28-34, 1976

Studies on epidemiology and control of filariasis. HI. Mass treatment with diethylcarbamazine for populations in edemic area of bancroftian of filariasis. Endemic Dis Bull Nagasaki Univ 3(4): 289-298, 1962

Effects of combined diethylcarbamazine and albendazole treatment of bancroftian filariasis on parasite uptake and development in Culex pipiens L. American Journal of Tropical Medicine and Hygiene 73(1): 108-114, 2005

Research into the control of bancroftian filariasis by mass treatment with diethylcarbamazine. Recent developments in medical research in eastern Africa Proceedings of the 1st Annual Medical Scientific Conference of the Kenya Medical Research Institute and Kenya Trypanosomiasis Research Institute, 29 January to 1 February 1980, Nairobi, Kenya: 291-292, 1980

Duration of diethylcarbamazine treatment and clearance of microfilaraemia in bancroftian filariasis. Journal of Communicable Diseases 12(1): 34-38, 1980

Control of bancroftian filariasis in rural areas through selected treatment with diethylcarbamazine. Journal of Communicable Diseases 18(4): 283-286, 1986

A single dose of doxycycline in combination with diethylcarbamazine for treatment of bancroftian filariasis. Southeast Asian Journal of Tropical Medicine and Public Health 41(4): 800-812, 2010

Control of bancroftian filariasis in a rural area through selected treatment with diethylcarbamazine. Journal of Communicable Diseases 19(4): 322-325, 1987

Evaluation of the therapeutic effect of diethylcarbamazine (Hetrazan) in Bancroftian filariasis using various technique in Upper Egypt. Journal of the Egyptian Society of Parasitology 11(2): 373-379, 1981

Effects of ivermectin and diethylcarbamazine on microfilariae and overall microfilaria production in bancroftian filariasis. American Journal of Tropical Medicine and Hygiene 73(5): 881-887, 2005